Name: ABUS Income Statement - Arbutus Biopharma Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ABUS - Arbutus Biopharma Corp.

USD | NASDAQ | Healthcare

ABUS Income Statement - Arbutus Biopharma Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	179.1	1.1	0.5	10.7	1.8	1.6	1.3	1.7	1.5	2.1	4.7	4.7	6.7	6.2	6.0	14.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
Revenues
Revenues	191.4	14.1	6.2	18.1	39.0	11.0	6.9	6.0	5.9	10.7	1.5	23.3	15.0	15.5	14.1	16.8	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses
Research & Development	20.4	25.2	54.0	73.7	84.4	65.5	49.3	57.6	57.9	62.7	61.3	51.5	38.7	21.5	18.0
Operating Income
Operating Income	156.4	(38.2)	(76.3)	(78.1)	(65.5)	(73.5)	(57.8)	(143.9)	(89.8)	(110.9)	(491.6)	(103.9)	(33.4)	(12.2)
Non-Operating
Interest Income	3.7	4.1	6.6	5.7	2.2	0.1	0.7	2.1	3.0	1.5	1.4	0.7	0.9	0.5	0.1	0.1
Tax & Net
Income Tax Expense	-	0.0	0.0	0.0	4.4	0.0	0.0	(12.7)	(4.3)	(24.3)	(105.0)	(16.2)	0.0	0.0	-
Per Share
EPS Basic	0.83	(0.17)	(0.38)	(0.44)	(0.46)	(0.83)	(1.00)	-	(1.21)	(1.56)	(7.24)	(1.38)	(1.80)	(0.92)	2.16	(0.89)
Supplementary Data
EBITDA	-	(37.8)	(74.9)	(76.7)	(64.0)	(71.8)	(55.8)	(141.9)	(87.6)	(108.9)	(490.5)	(103.3)	(32.9)	(11.5)	(12.1)	(9.7)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	4.1	5.0	5.8	5.5	9.0	8.8	14.3	15.6	15.4	17.6	20.2	17.7	18.3	22.9	20.1	22.9	18.5	19.2	16.7	15.8	13.8	16.4	12.1	10.5	10.4	12.4	17.7	12.7	14.7	11.1	16.6	16.4	13.9	17.8	15.5	15.4	13.9	17.2	15.7	15.2
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	5.9	3.7	3.0	3.3	5.8	4.7	4.5	7.5	5.3	5.1	5.8	6.0	5.6	4.2	3.5	5.2	4.9
Depreciation & Amortization	0.0	-	-	-	0.3	-	-	-	0.4	-	-	-	0.3	-	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	10.2	6.3	9.2	9.3	27.5	15.5	22.8	23.3	20.9	22.9	26.2	23.0	24.1	28.8	23.8	28.4

Operating Income
Operating Income	168.9	(5.3)	(8.7)	1.5	(25.7)	(13.9)	(21.4)	(21.6)	(19.4)	(20.7)	(21.6)	(18.4)	(17.4)	(22.6)	(17.8)	(14.1)	(11.0)	(20.8)	(18.4)	(18.6)	(15.7)	(16.3)	(15.2)	(13.1)	(13.1)	(13.0)	(91.0)	(20.6)	(19.2)	(16.9)	(32.4)	(22.0)	(18.4)	(60.2)	(12.9)	(19.5)	(18.3)	(257.4)	(19.0)	(195.2)

Tax & Net
Income Tax Expense	0.0	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	(12.7)	0.0	0.0	-	(4.3)	-	-	-	0.0	0.0	-	-	0.0	(64.9)
Net Income From Continuing Ops	169.7	(3.8)	(7.7)	2.5	(24.5)	(12.5)	(19.7)	(19.8)	(17.9)	(19.3)	(20.1)	(17.1)	(16.3)	(21.9)	(17.6)	(14.2)	(15.8)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	169.7	(3.8)	(7.7)	2.5	(24.5)	(12.5)	(19.7)	(19.8)	(17.9)	(19.3)	(20.1)	(17.1)	(16.3)	(21.9)	(17.6)	(14.2)	(15.8)
Net Income Attributable To Parent	169.7	(3.8)	(7.7)	2.5	(24.5)	(12.5)	(19.7)	(19.8)	(17.9)	(19.3)	(20.1)	(17.1)	(16.3)	(21.9)	(17.6)	(14.2)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.0
Net Income To Common Shareholders	169.7	(3.8)	(7.7)	2.5	(24.5)	(12.5)	(19.7)	(19.8)	(17.9)	(19.3)	(20.1)	(17.1)	(16.3)	(21.9)	(17.6)

Per Share
EPS Basic	0.88	-	(0.04)	0.01	(0.13)	-	(0.10)	(0.11)	(0.10)	-	(0.12)	(0.10)	(0.10)	-	(0.12)	(0.10)	(0.11)	-	(0.24)	(0.23)	(0.21)	-	(0.27)	(0.25)	(0.25)	-	-	(0.46)	-	-	-	0.01	-	-	-	(0.33)	-	-	-	-
EPS Diluted	0.87	-	(0.04)	0.01	(0.13)	-	(0.10)	(0.11)	(0.10)	-	(0.12)	(0.10)	(0.10)	-	(0.12)	(0.10)	(0.11)	-
Shares Basic	193.8	-	191.8	191.6	190.7	-	189.0	188.0	175.6	-	167.5	166.1	161.6	-	151.0	148.8	148.4	-
Shares Diluted	195.2	-	191.8	192.4	190.7	-	189.0	188.0	175.6	-	167.5	166.1	161.6	-	151.0	148.8	148.4	-

Supplementary Data
EBITDA	168.9	-	-	-	(25.4)	-	-	-	(19.0)	-	-	-	(17.1)	-	-	-	(10.6)	(20.4)	(18.0)	(18.2)	(15.2)	(15.8)	(14.7)	(12.6)	(12.6)	(12.5)	(90.5)	(20.1)	(18.7)	(16.4)	(31.9)	(21.5)	(17.8)	(59.6)	(12.3)	(19.0)	(18.0)	(257.1)	(18.7)	(195.0)
EBIT	168.9	(5.3)	(8.7)	1.5	(25.7)	(13.9)	(21.4)	(21.6)	(19.4)	(20.7)	(21.6)	(18.4)	(17.4)	(22.6)	(17.8)	(14.1)	(11.0)	(20.8)	(18.4)

Non-Operating
Interest Income	0.8	0.9	1.0	1.0	1.2	1.5	1.7	1.8	1.5	1.5	1.5	1.5	1.3	0.9	0.7	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.4	0.5	0.6	0.6	0.7	0.8	0.8	0.8	0.4	0.3	0.4	0.4	0.3	0.4	0.4
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.4	0.5	0.5	0.6
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	0.8	1.5	0.9	1.0	1.2	1.4	1.7	1.8	1.5	1.4	1.5	1.3	1.1	0.6	0.2	(0.1)	(0.3)
Pre-Tax Income	-	-	-	-	-	-	-	-	-	-	(20.1)	(17.1)	(16.3)	-	(17.6)	(14.2)	(11.3)